Housing aid linked to better prostate cancer survival in older adults
The hazard ratio for death was 0.88 for recipients versus nonrecipients over two years, indicating a lower relative death rate.
Our read
Populations- Studied:
- Cohort study of older adults with prostate cancer, 2 years
- What changed:
- Adjusted overall survival at two years was 84.4% with assistance versus 82.8% without it
- The catch:
- Models without the two-year cutoff found no overall or cancer-specific survival difference
- Stake:
- An author holds shares in Gilead Pharmaceuticals.
Editor of record: Boris Djordjevic · AgingResearch.News
Adults aged 66–95 diagnosed with prostate cancer in 2007–2019 were studied in a retrospective observational cohort. Researchers linked federal housing assistance records, cancer registry data and Medicare claims. They compared people receiving assistance continuously for at least six months before diagnosis with matched nonrecipients.
The survival analysis included 4,451 recipients and 13,353 nonrecipients. Adjusted overall survival at two years was 84.4% with assistance versus 82.8% without it. Survival from prostate cancer specifically did not differ significantly. Separate care analyses included 1,839 recipients and 5,517 nonrecipients. Housing assistance was not associated with recommended diagnostic testing or with active treatment in the first year after diagnosis.
Why it matters
The authors suggest that expanding access to housing assistance might support greater and more equitable survival among older adults with prostate cancer.
Caveats
This observational study could not establish causation and included only adults aged 66–95 with continuous fee-for-service Medicare coverage. Models without the two-year follow-up cutoff found no difference in overall or cancer-specific survival.
The paper
University of California, Los Angeles; Johns Hopkins University
Journal of the National Cancer Institute, Apr 22, 2026, Open access

Comments
Be the first to comment.